drugset / Trial / NCT04223037
Purified Inactivated Japanese Encephalitis Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study evaluates the immunogenicity and safety of a purified inactivated JE vaccine compared to a commercialized JE vaccine. In this phase III, randomized, blind trial, infants at 6-23 months of age were randomly assigned to three groups to receive experimental vaccine or control vaccine with two different vaccination schedule respectively.
Timeline
- Start
- 2015-09-01
- Primary completion
- 2018-03-07
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Japanese Encephalitis Vaccine produced by IMBCAMS | Vaccine | 0.5 ml | — |
| Comparator | Japanese Encephalitis Vaccine produced by Liaoning Chenda | Vaccine | 0.5 ml | — |